IONS - Company ID 0000874015
The table below shows IONIS PHARMACEUTICALS INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q1 2021 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$792.82M | -$150.78M | -$149.94M | -$133.99M | -$31.65M | -$54.66M |
| Capital expenditure | $21.76M | $12.58M | $4.49M | $10.47M | $2.71M | $1.77M |
| Investing cash flow | $536.82M | $170.46M | $76.11M | -$325.64M | -$287.55M | $78.86M |
| Dividends paid | - | - | - |
IONIS PHARMACEUTICALS INC reported operating cash flow of -$268.58M for fiscal year 2025. That is up 46.4% from -$500.95M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$112.11M (FY 2016) to -$268.58M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| - |
| - |
| Stock buybacks | - | - | - | - | - | $0.00 |
| Financing cash flow | $57.26M | $2.20M | $23.57M | $492.09M | -$7.33M | -$7.58M |